Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,959
  • Shares Outstanding, K 5,143
  • Annual Sales, $ 5,390 K
  • Annual Income, $ -8,620 K
  • 60-Month Beta 1.23
  • Price/Sales 7.39
  • Price/Cash Flow N/A
  • Price/Book 4.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -1.44
  • Growth Rate Est. (year over year) +61.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.94 +12.97%
on 09/03/20
9.08 -13.66%
on 08/25/20
-1.16 (-12.89%)
since 08/24/20
3-Month
6.94 +12.97%
on 09/03/20
14.84 -47.17%
on 07/17/20
+0.22 (+2.89%)
since 06/24/20
52-Week
2.52 +211.11%
on 03/16/20
19.69 -60.18%
on 11/12/19
-2.74 (-25.90%)
since 09/24/19

Most Recent Stories

More News
Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT(R) Platform to Textiles Including Those Used in Personal Protective Equipment

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based...

ITW : 192.34 (+0.79%)
APDN : 7.84 (+0.90%)
Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, preclinical nucleic acid-based...

APDN : 7.84 (+0.90%)
Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based...

APDN : 7.84 (+0.90%)
Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), announced that the Company's wholly owned diagnostics testing subsidiary, Applied DNA Clinical Labs, LLC ("ADCL"), has completed...

APDN : 7.84 (+0.90%)
The global market for anti-counterfeit packaging is projected to grow from USD 106.3 billion in 2020 to reach USD 188.2 billion by 2025, at an estimated CAGR of 12.09%

, /PRNewswire/ --Read the full report: The global market for anti-counterfeit packaging is projected to grow from in 2020 to reach by 2025, at an estimated CAGR of 12.09%. The anti-counterfeit packaging...

APDN : 7.84 (+0.90%)
CCDBF : 35.8400 (-1.82%)
ZBRA : 250.67 (+0.44%)
Applied DNA Positions LinearDNA(TM) Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based...

APDN : 7.84 (+0.90%)
Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced...

APDN : 7.84 (+0.90%)
Applied DNA Sciences: Fiscal 3Q Earnings Snapshot

STONY BROOK, N.Y. (AP) _ Applied DNA Sciences Inc. (APDN) on Thursday reported a loss of $3.3 million in its fiscal third quarter.

APDN : 7.84 (+0.90%)
Applied DNA Reports Fiscal Third Quarter 2020 Financial Results

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based...

APDN : 7.84 (+0.90%)
Thinking about buying stock in Achieve Life Sciences, Applied DNA Sciences, Delta Air Lines, Carnival Corp, or MGM Resorts?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACHV, APDN, DAL, CCL, and MGM.

ACHV : 8.64 (-3.25%)
APDN : 7.84 (+0.90%)
CCL : 13.74 (-2.76%)
DAL : 29.01 (-1.86%)
MGM : 21.19 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade APDN with:

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

2nd Resistance Point 8.02
1st Resistance Point 7.93
Last Price 7.84
1st Support Level 7.70
2nd Support Level 7.56

See More

52-Week High 19.69
Fibonacci 61.8% 13.13
Fibonacci 50% 11.11
Fibonacci 38.2% 9.08
Last Price 7.84
52-Week Low 2.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar